DR. DIANA FELICE HAUSMAN, M.D.
Medical Practice at 4 Ave, Seattle, WA
License number
Washington MD00028758
Category
Medical Practice
Type
Specialist
Address
Address
2601 4Th Ave SUITE 500, Seattle, WA 98121
Phone
(206) 801-2116
(206) 527-2648
(206) 527-2648
Personal information
See more information about DIANA FELICE HAUSMAN at radaris.comName
Address
Phone
2339 Federal Ave E, Seattle, WA 98102
Seattle, WA
2339 Federal Ave E, Seattle, WA 98102
Professional information
See more information about DIANA FELICE HAUSMAN at trustoria.com
Dr. Diana F Hausman, Seattle WA - MD (Doctor of Medicine)
Dr. Diana F Hausman, Seattle WA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
2339 Federal Ave E, Seattle 98102
2601 4Th Ave SUITE 500, Seattle 98121
(206) 801-2116 (Phone)
2601 4Th Ave SUITE 500, Seattle 98121
(206) 801-2116 (Phone)
Certifications:
Internal Medicine, 1992, Medical Oncology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Perelman School of Medicine University of Pennsylvania
Graduated: 1989
Univ Wash Affil Hosp
Perelman School of Medicine University of Pennsylvania
Graduated: 1989
Univ Wash Affil Hosp
Diana Hausman
Diana Hausman
Location:
Greater Seattle Area
Industry:
Biotechnology
Skills:
Oncology, Medicine, Clinical Development, Drug Development, Hematology, Clinical Research, Internal Medicine, Clinical Trials, Clinical Study Design, Pharmacovigilance
Diana Hausman, Seattle WA
Diana Hausman, Seattle WA
Work:
Oncothyreon
2601 4Th Ave, Seattle, WA 98121 Zymogenetics, Inc.
1201 Eastlake Ave E, Seattle, WA 98102
2601 4Th Ave, Seattle, WA 98121 Zymogenetics, Inc.
1201 Eastlake Ave E, Seattle, WA 98102
Diana Felice Hausman, Seattle WA
Diana Felice Hausman, Seattle WA
Specialties:
Oncologist
Address:
2601 4Th Ave, Seattle, WA 98121
Interleukin 21 And Tyrosine Kinase Inhibitor Combination Therapy
Interleukin 21 And Tyrosine Kinase Inhibitor Combination Therapy
US Patent:
2008002, Jan 31, 2008
Filed:
Jul 13, 2007
Appl. No.:
11/777852
Inventors:
Pallavur Sivakumar - Seattle WA, US
Diana Hausman - Seattle WA, US
Steven Hughes - Kenmore WA, US
Eric Sievers - Seattle WA, US
Dennis Miller - Woodinville WA, US
Diana Hausman - Seattle WA, US
Steven Hughes - Kenmore WA, US
Eric Sievers - Seattle WA, US
Dennis Miller - Woodinville WA, US
International Classification:
A61K 38/20, A61K 31/44, A61P 35/00
US Classification:
424085200, 514346000
Abstract:
The present invention provides methods for use of IL-21 in combination with a tyrosine kinase inhibitor (TKI) in treatment of diseases in which inhibition of phosphorylation via TK inhibition and modulation of immune function play a clinically beneficial role. These diseases include, but are not limited to, cancers, such as renal cell carcinoma and metastatic melanoma.
Muc1 Based Glycolipopeptide Vaccine With Adjuvant
Muc1 Based Glycolipopeptide Vaccine With Adjuvant
US Patent:
2012028, Nov 8, 2012
Filed:
Jul 19, 2012
Appl. No.:
13/553061
Inventors:
Scott PETERSON - Woodinville WA, US
Linda Pestano - Tucson AZ, US
Jeffrey Millard - Seattle WA, US
Diana F. Hausman - Seattle WA, US
Sandy Koppenol - Lake Forest Park WA, US
Robert Kirkman - Yarrow Point WA, US
Linda Pestano - Tucson AZ, US
Jeffrey Millard - Seattle WA, US
Diana F. Hausman - Seattle WA, US
Sandy Koppenol - Lake Forest Park WA, US
Robert Kirkman - Yarrow Point WA, US
Assignee:
Oncothyreon Inc. - Seattle WA
International Classification:
A61K 39/00, A61P 35/02, A61P 37/04, A61K 9/127, A61P 35/00
US Classification:
424450, 4241851
Abstract:
Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.
Muc1 Based Glycolipopeptide Vaccine With Adjuvant
Muc1 Based Glycolipopeptide Vaccine With Adjuvant
US Patent:
2012021, Aug 30, 2012
Filed:
Feb 23, 2012
Appl. No.:
13/403679
Inventors:
Scott PETERSON - Woodinville WA, US
Linda Pestano - Tucson AZ, US
Jeffrey Millard - Seattle WA, US
Diana F. Hausman - Seattle WA, US
Sandy Koppenol - Lake Forest Park WA, US
Robert Kirkman - Yarrow Point WA, US
Linda Pestano - Tucson AZ, US
Jeffrey Millard - Seattle WA, US
Diana F. Hausman - Seattle WA, US
Sandy Koppenol - Lake Forest Park WA, US
Robert Kirkman - Yarrow Point WA, US
Assignee:
Oncothyreon Inc. - Seattle WA
International Classification:
A61K 9/127, A61K 39/395, A61P 37/04, A61P 35/02, A61K 39/00, A61P 35/00
US Classification:
424450, 4241851, 4241331
Abstract:
Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer.
Cancer Treatment With Wortmannin Analogs
Cancer Treatment With Wortmannin Analogs
US Patent:
2013013, May 23, 2013
Filed:
Jun 3, 2011
Appl. No.:
13/701270
Inventors:
Scott Peterson - Woodinville WA, US
Diana F. Hausman - Seattle WA, US
Robert Kirkman - Yarrow Point WA, US
Diana F. Hausman - Seattle WA, US
Robert Kirkman - Yarrow Point WA, US
Assignee:
ONCOTHYREON INC. - Seattle WA
International Classification:
C07J 73/00
US Classification:
514453
Abstract:
Provided herein are certain therapeutically effective dosing regimens for treatment of cancers with wortmannin analogs.
Combination Cancer Therapies With Wortmannin Analogs
Combination Cancer Therapies With Wortmannin Analogs
US Patent:
2013012, May 23, 2013
Filed:
Jun 3, 2011
Appl. No.:
13/701290
Inventors:
Scott Peterson - Woodinville WA, US
Diana F. Hausman - Seattle WA, US
Robert Kirkman - Yarrow Point WA, US
Diana F. Hausman - Seattle WA, US
Robert Kirkman - Yarrow Point WA, US
Assignee:
ONCOTHYREON INC. - Seattle WA
International Classification:
A61K 31/366, A61K 39/395, A61K 45/06, A61K 31/337, A61K 31/56
US Classification:
4241331, 514453, 514171
Abstract:
Provided herein are combination therapies for the treatment of certain cancers in a subject by administering a combination of a therapeutic and a wortmannin analog to that subject.